Hong Kong-based EMQ raises $20 million Series B led by WI Harper Group

[vc_row][vc_column][vc_column_text]WI Harper Group | July 30, 2020   Source: Techcrunch[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1596148622018{background-color: #e4e4e4 !important;}”]WI Harper Group recently led the USD $20 million Series B financing of EMQ, a leading financial settlement network company in Asia. EMQ will use this round of funds to further accelerate product development and international business expansion in Asia, Europe and America.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image source=”external_link” external_img_size=”500×400″ alignment=”center” custom_src=”https://wiharper.com/wp-content/uploads/2020/07/Picture-EMQ-1.png” caption=”Image Credits: Chuanchai Pundej / EyeEm / Getty Images”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Cross-border financial transactions are a major headache for individuals and large companies alike, who often have to deal with long wait times and high fees in order to send money to recipients in other countries. EMQ, a Hong Kong-based startup that develops network infrastructure to make international payments faster, announced today that it has raised a $20 million Series B led by WI Harper Group.[/vc_column_text][vc_column_text]EMQ’s technology is integrated by clients, including online banks, digital wallets, e-commerce settlement providers and licensed financial institutions, into their existing networks, making it easier for them to perform cross-border remittances.[/vc_column_text][vc_column_text]The funding, which also included participation from AppWorks, Abu Dhabi Capital, DG Ventures, Intudo Ventures, VS Partners, January Capital, Hard Yaka, Vectr Fintech Partners, Quest Venture Partners and SparkLabs. Proceedswill be used for expanding EMQ’s international business, product development and licensing in key markets. Its last funding was a $6.5 million Series A in December 2017.[/vc_column_text][vc_column_text]EMQ is already licensed in Hong Kong, Singapore and Indonesia, and is registered as a Money Service Business in Canada. It has also been accepted into the regulatory sandbox launched by Taiwan’s Financial Supervisory Commission to encourage innovation by financial tech companies.[/vc_column_text][vc_column_text]The company’s co-founder and chief executive officer Max Liu told TechCrunch that EMQ will focus on scaling its operations, especially for business remittances, in China, followed by India and Japan. EMQ’s tech is already used to process business payments in 80 countries.[/vc_column_text][vc_column_text]Until recently, the majority of transactions facilitated by EMQ were between consumers. Then in May, the company launched its enterprise payment solution for companies. Liu said EMQ now expects business-to-business transactions to account for half of its gross transaction volume in 2021.[/vc_column_text][vc_column_text]According to Juniper Research, cross-border B2B transactions are expected to exceed $218 trillion by 2022, up from $150 trillion in 2018, thanks in large part to the adoption of new technology. Other fintech companies that also provide tech, including APIs, for cross-border transactions, include Currencycloud, Payoneer and TransferWise.[/vc_column_text][vc_column_text]Liu said EMQ’s main selling point is that it is focused on building a flexible infrastructure that can handle a large range of use cases in different countries, including e-commerce, merchant settlement, procurement, remittance and payroll.[/vc_column_text][vc_column_text]He added that EMQ can be integrated into a client’s existing tech infrastructure with as little as two API calls. EMQ gives clients a fully functional sandbox environment, which mimics real transactions, and allows them to experiment with its tech and work with EMQ’s customer support team before it is formally deployed. Liu said it usually takes clients between two weeks to two months, depending on a company’s size and requirements, to fully integrate EMQ into their business operations.[/vc_column_text][vc_column_text]In a press statement about the investment, Edward Liu, a partner at WI Harper Group, said, “As digital transformation intensifies globally, enterprises today are increasingly international in scale and they will require a network infrastructure like EMQ with greater speed, more certainty, increased flexibility and transparency, to expand their business in Asia and beyond. We are excited to partner with the EMQ team to expand its market-leading position in cross-border business payments globally.”[/vc_column_text][/vc_column][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]| About WI Harper Group:[/vc_column_text][vc_column_text]WI Harper is a pioneer and leading cross-border venture capital firm investing in early and expansion stage companies globally. With offices in San Francisco, Beijing, and Taipei, the firm actively oversees more than $1 billion in assets under management. Since inception nearly three decades ago, WI Harper has invested in over 400 startups and has successfully experienced more than 100 IPO and M&A exits.

 

We look for innovative companies and visionary founders in healthcare, technology and sustainability fields where there are high synergies and meaningful value added cross selling opportunities. While our healthcare team is presently honing on bioinformatics and digital biology, our technology team is focused blockchain, big data, analytics, artificial intelligence, AR/VR, IoT, robotics, drones, autonomous driving, as well as digital media and green energy projects.

[/vc_column_text][/vc_column][/vc_row]

Hong Kong-based EMQ raises $20 million Series B led by WI Harper Group

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.